The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Miofen 200mg Film-coated Tablet

Alter PharmaPA22983/001/001

Main Information

Trade NameMiofen 200mg Film-coated Tablet
Active SubstancesIbuprofen
Dosage FormFilm-coated tablet
Licence HolderAlter Pharma
Licence NumberPA22983/001/001

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE01 ibuprofen


License statusAuthorised
Licence Issued24/07/2015
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceSupply through pharmacies only and promotion to the public subject to the the following restrictions: maximum strength 200 mg, maximum pack size 50, maximum dose 400mg, maximum daily dose 1200 mg, limited indications
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back